Fused tricyclic compounds useful as anticancer agents

MA55198AUndetermined Publication Date: 2022-01-12ASTRAZENECA AB

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA55198
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2019-12-20
Filing Date: 2020-03-03
Publication Date: 2022-01-12

Application Information

Patent Timeline

20 Dec 2019

Priority

03 Mar 2020

Application

MA55198

12 Jan 2022

Publication

MA55198A

IPC: A61K31/553; A61P35/00; C07D487/04; C07D498/04; C07D498/14; C07D498/22

CPC: C07D498/04; C07D487/04; C07D498/14; C07D498/22; A61P35/00; A61K31/553; A61K31/551; C07B2200/05

Inventors: BODNARCHUK Michael Steven; BOYD Scott

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.